Exchange: NASDAQ·Updated 04:52 PM EDT
CLDX logo

CLDX Celldex Therapeutics Inc.

$39.89
$0.24
(0.61%)
Today
Closed $39.48
$0.41
(1.04%)
After Hours
Reported EarningsAug 6
Mkt Cap$3.08B
Vol476,382.00

About CLDX

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
38

Bearish Sentiment

How do you feel about CLDX?

Advertisement|Remove ads.